Expand FBIO Menu
FBIO MENU

FBIO Latest Press Releases

-- August 13, 2026 --

Fortress Biotech Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights Globe Newswire 4:05 PM

-- August 12, 2026 --

Journey Medical Corporation Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights Globe Newswire 4:01 PM

-- August 7, 2026 --

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of an Investigation Concerning Possible Breaches of Fiduciary Duties by Certain Officers and Directors of Fortress Biotech, Inc. (NASDAQ: FBIO) PRNewswire 12:45 PM

-- August 5, 2026 --

Journey Medical Corporation to Announce Second Quarter 2026 Financial Results on August 12, 2026 Globe Newswire 8:30 AM

-- July 27, 2026 --

Fortress Biotech and Subsidiary Urica Therapeutics Announce Crystalys Therapeutics' $130 Million Series B Financing Globe Newswire 8:00 AM

-- May 19, 2026 --

Journey Medical Corporation to Participate in A.G.P.'s Annual Virtual Healthcare Conference Globe Newswire 4:45 PM

-- May 18, 2026 --

Fortress Biotech to Participate in A.G.P.'s Annual Virtual Healthcare Conference Globe Newswire 8:30 AM

-- May 14, 2026 --

Fortress Biotech Reports First Quarter 2026 Financial Results and Recent Corporate Highlights Globe Newswire 4:10 PM

-- May 13, 2026 --

Journey Medical Corporation Reports First Quarter 2026 Financial Results and Recent Corporate Highlights Globe Newswire 4:01 PM

-- May 6, 2026 --

Journey Medical Corporation to Announce First Quarter 2026 Financial Results on May 13, 2026 Globe Newswire 4:01 PM

-- May 4, 2026 --

Fortress Biotech to Participate in the H.C. Wainwright 2nd Annual Royalty Company Virtual Conference Globe Newswire 8:30 AM

-- April 21, 2026 --

Journey Medical Corporation Secures Contract with Third Major GPO for Emrosi Globe Newswire 8:30 AM

-- March 31, 2026 --

Fortress Biotech Reports 2025 Financial Results and Recent Corporate Highlights Globe Newswire 4:05 PM

-- March 30, 2026 --

Fortress Biotech's Subsidiary Cyprium Therapeutics Closes Sale of Rare Pediatric Disease Priority Review Voucher for $205 Million Globe Newswire 4:05 PM
Market Data Delayed 15 Minutes